MARINA BIOTECH INC COM STK (DE)
MRNA
MRNA was delisted on the 1st of February, 2012.
2 hedge funds and large institutions have $27.3K invested in MARINA BIOTECH INC COM STK (DE) in 2026 Q1 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 1 reducing their positions, and closing their positions.
69% more capital invested
Capital invested by funds: $16.2K → $27.3K (+$11.2K)
0% more funds holding
Funds holding: 2 → 2 (0)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BAM
Byrne Asset Management
Kingston,
New Jersey
|
-$508 |
MRNA Hedge Fund Activity: Q1 2026 in Review
2 of the 8,132 institutional investors tracked by Wall St. Rank reported a position in MARINA BIOTECH INC COM STK (DE) (MRNA) for Q1 2026, worth a combined $27.3K — up 69% from $16.2K a quarter earlier.
Fund positioning in MRNA was balanced in Q1 2026: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was Byrne Asset Management, cutting an estimated $508.
- 2 institutional investors held MARINA BIOTECH INC COM STK (DE) (MRNA) as of Q1 2026, unchanged from Q4 2025.
- Funds reported $27.3K of MARINA BIOTECH INC COM STK (DE) stock for Q1 2026, up 69% quarter-over-quarter.
- 0 funds opened new MARINA BIOTECH INC COM STK (DE) positions in Q1 2026 and 0 closed out.
- The largest MARINA BIOTECH INC COM STK (DE) seller in Q1 2026 was Byrne Asset Management, an estimated $508 sold.
Based on aggregated 13F filings for Q1 2026.